ASX Share rice
Mon 17 May 2021 - 05:00:am (Sydney)

RHY Share Price

RHYTHM BIOSCIENCES LIMITEDRHYHealth Care Equipment & Services

RHY Company Information

Name:

Rhythm Biosciences Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

Address:

Bio21 Institute Parkville VIC Australia 3010

Phone:

61 3 9614 0600

CEO & COO:

Mr. Glenn Gilbert

Technical Director, Chair of the Clinical Advisory Board & Director:

Dr. Trevor John Lockett Ph.D.

Company Sec.:

Mr. Adrien Michele Wing C.P.A., B.Bus, B.Acc, CPA

Joint Company Sec.:

Ms. Pauline Moffatt

Company Overview:

Rhythm Biosciences Limited engages in developing and commercializing medical diagnostics technology in Australia and internationally. It is developing ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

RHY Share Price Information

Shares Issued:

202.17M

Market Capitalisation:

$176.90M

Revenue (TTM):

$1.21M

Revenue Per Share (TTM):

$0.01

Earnings per Share:

$-0.025

Operating Margin (TTM):

$-3.43

Return On Assets (TTM):

$-0.46

Return On Equity (TTM):

$-0.81

Quarterly Revenue Growth (YOY):

-0.866

Gross Profit(TTM):

$100K

Diluted Earnings Per Share (TTM):

$-0.031

RHY CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-45,535

Change To Liabilities:

$361.82K

Total Cashflow From Investing Activities:

$-45,535

Net Borrowings:

$-142,224

Net Income:

$-4,022,984

Total Cash From Operating Activities:

$-2,742,598

Depreciation:

$141.29K

Change To Account Receivables:

$658.52K

Capital Expenditures:

$45.54K

RHY Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-4,022,980

Net Income:

$-4,022,980

Gross Profit:

$-1,351,530

Operating Income:

$-4,015,180

Interest Expense:

$7.80K

Total Revenue:

$46.27K

Cost Of Revenue:

$1.40M

RHY Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$497.99K

Total Liabilities:

$802.85K

Total Stockholder Equity:

$1.84M

Total Assets:

$2.65M

Common Stock:

$10.04M

Retained Earnings:

$-8,388,186

Other Liabilities:

$8.43K

Cash:

$1.80M

Total Current Liabilities:

$794.42K

Property - Plant & Equipment:

$142.56K

Net Tangible Assets:

$1.35M

Total Current Assets:

$2.01M

Net Receivables:

$139.18K

Short-Term Investments:

$640.54K

Accounts Payable:

$560.54K

Short-Term Investments:

$640.54

Non Current Liabilities Total:

$8.43K

RHY Share Price History

RHY News

03 Mar, 2021
There's no doubt that money can be made by owning shares of unprofitable businesses. By way of example, Rhythm...
03 Dec, 2020
Every investor in Rhythm Biosciences Limited ( ASX:RHY ) should be aware of the most powerful shareholder groups. Large...